Tatva Chintan

TATVA03 May 2024

Chemicals

₹

+18.55 (+1.51%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Tatva Chintan

Tatva Chintan

Chemicals

TATVA03 May 2024

₹

+18.55 (+1.51%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
05-May-2023	D	Outcome Of The Board Meeting Held On 05.05.2023 Intimation of Record date, Book Closure and Cut-off date pursuant to Regulation 42 and 44 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) (As Per BSE Announcement dated on 26.08.2023)	08-Sep-2023
25-Apr-2022	D	The Board Recommended a Final Dividend of Rs. 2/- (20%) per equity share of Rs. 10/- each fully paid (subject to deduction of tax, if any) on the equity share capital of Rs. 22,16,50,620/- (2,21,65,062 equity shares of Rs. 10/- each) for the financial year 2021-22. This shall be paid subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.	08-Sep-2022
24-Apr-2024	BC	Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2024 ,inter alia, to consider and approve 1. consider and approve and tak	03-May-2024
03-May-2024	BC	Board Meeting Outcome for Outcome Of The Board Meeting Held On 03.05.2024 The Board Recommended a Final Dividend of Rs. 2/- (20%) per equity share of Rs. 10/- each fully paid (subject to deductio	31-Mar-2024
11-Jan-2024	BC	Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2024 inter alia to consider and approve and take on record the Standalone	20-Jan-2024
20-Oct-2023	BC	Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2023 inter alia to consider and approve and take on record the Standalone	02-Nov-2023
18-Aug-2023	BC	Newspaper Advertisement - Disclosure under Regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. ('SEBI L	22-Sep-2023

No Rights has been declared by TATVA

Book Closure

Record Date	Split Date	Purpose
03-May-2024	-	Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/05/2024 ,inter alia, to consider and approve 1. consider and approve and tak
31-Mar-2024	-	Board Meeting Outcome for Outcome Of The Board Meeting Held On 03.05.2024 The Board Recommended a Final Dividend of Rs. 2/- (20%) per equity share of Rs. 10/- each fully paid (subject to deductio
20-Jan-2024	-	Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/01/2024 inter alia to consider and approve and take on record the Standalone
02-Nov-2023	-	Tatva Chintan Pharma Chem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2023 inter alia to consider and approve and take on record the Standalone
22-Sep-2023	-	Newspaper Advertisement - Disclosure under Regulation 30 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. ('SEBI L

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Tatva Chintan Pharma Chem Ltd ₹1,245.55(+18.55/1.51%)	1,245.55	+18.55	2,913.60	-25.97	71.34	4.07
BASF India Ltd ₹4,065.05(+55.65/1.39%)	4,065.05	+55.65	17,597.60	70.18	37.21	6.01
Bhagawati Oxygen Ltd ₹50.26(-1.28/-2.48%)	50.26	-1.28	11.61	21.05	7.95	1.72
Atul Ltd ₹6,140.15(+142.35/2.37%)	6,140.15	+142.35	18,077.68	-6.68	47.01	3.55
Oriental Aromatics Ltd ₹372.65(+12.70/3.53%)	372.65	+12.70	1,254.10	-7.28	0.00	2.02
Advance Petrochemicals Ltd ₹218.40(+10.40/5.00%)	218.40	+10.40	19.66	-50.24	0.00	5.65

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Gross Sales	93.93	86.07	92.57	106.11	119.41	113.54
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	93.93	86.07	92.57	106.11	119.41	113.54
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	4.53	1.21	0.76	1.02	0.78	1.07
Total Income	98.46	87.28	93.33	107.12	120.19	114.61
Total Expenditure	79.73	73.76	71.83	86.49	107.59	96.69
PBIDT	18.73	13.52	21.50	20.63	12.60	17.92
Interest	0.22	0.38	3.01	2.90	3.18	2.38
PBDT	18.51	13.15	18.48	17.73	9.42	15.54
Depreciation	6.23	6.58	6.78	6.01	2.53	2.38
Tax	2.13	1.32	1.86	2.04	-4.46	2.14
Deferred Tax	1.90	0.59	1.65	1.43	-4.80	0.46
Reported Profit After Tax	8.25	4.65	8.20	8.25	16.15	10.56
Extra-ordinary Items	0.00	0.00	0.00	0.00	-3.59	0.00
Adjusted Profit After Extra-ordinary item	8.25	4.65	8.20	8.25	19.74	10.56

EPS (Unit Curr.)	3.52	1.99	3.63	3.72	7.29	4.76
EPS (Adj) (Unit Curr.)	3.52	1.99	3.63	3.72	7.29	4.76
Calculated EPS (Unit Curr.)	3.53	1.99	3.51	3.72	7.29	4.76
Calculated EPS (Adj) (Unit Curr.)	3.53	1.99	3.51	3.72	7.29	4.76
Calculated EPS (Ann.) (Unit Curr.)	14.10	7.95	14.03	14.88	29.15	19.05
Calculated EPS (Adj) (Ann.) (Unit Curr.)	14.10	7.95	14.03	14.88	29.15	19.05
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	23.39	23.39	23.39	22.17	22.17	22.17
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	19.94	15.71	23.23	19.44	10.55	15.78
PBDTM(%)	19.71	15.28	19.96	16.71	7.89	13.69
PATM(%)	8.78	5.40	8.86	7.77	13.52	9.30

Column	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Gross Sales	98.27	84.21	96.67	114.36	124.51	120.61
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	98.27	84.21	96.67	114.36	124.51	120.61
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	4.53	1.21	0.76	1.02	0.85	1.08
Total Income	102.79	85.42	97.43	115.38	125.36	121.68
Total Expenditure	82.66	73.21	76.42	93.02	111.82	102.69
PBIDT	20.14	12.20	21.00	22.36	13.53	18.99
Interest	0.21	0.38	3.01	2.93	3.20	2.38
PBDT	19.92	11.83	17.99	19.43	10.33	16.61
Depreciation	6.23	6.58	6.78	6.01	2.53	2.38
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	2.17	1.20	1.78	2.49	-4.35	2.14
Deferred Tax	1.90	0.59	1.65	1.43	-4.80	0.46
Reported Profit After Tax	9.61	3.46	7.78	9.50	16.95	11.62
Minority Interest After NP	0.00	0.00	0.00	0.00	0.00	0.00
Net Profit after Minority Interest	9.61	3.46	7.78	9.50	16.95	11.62

Extra-ordinary Items	0.00	0.00	0.00	0.00	-3.59	0.00
Adjusted Profit After Extra-ordinary item	9.61	3.46	7.78	9.50	20.54	11.62

EPS (Unit Curr.)	4.11	1.48	3.43	4.29	7.65	5.24
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	23.39	23.39	23.39	22.17	22.17	22.17

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	20.49	14.49	21.72	19.55	10.87	15.74
PBDTM(%)	20.27	14.05	18.61	16.99	8.30	13.77
PATM(%)	9.78	4.11	8.05	8.31	13.61	9.63

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	22.17	22.17	20.09	8.04	8.04	8.04
Reserves Total	482.62	446.71	141.85	106.41	71.60	51.45
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	504.79	468.88	161.94	114.45	79.64	59.49
Secured Loans	170.26	119.94	90.25	90.69	77.15	56.15
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	170.26	119.94	90.25	90.69	77.15	56.15
Total Liabilities	675.05	588.82	252.19	205.14	156.79	115.64
APPLICATION OF FUNDS :
Gross Block	231.75	186.14	138.88	122.48	73.45	59.98
Less : Accumulated Depreciation	35.53	26.53	18.43	11.30	6.74	2.95
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	196.22	159.61	120.45	111.18	66.71	57.03
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	230.74	51.49	9.81	4.89	6.04	9.94
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.67	0.67	0.67	0.67	0.67	1.20
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	151.45	160.69	68.36	58.72	31.06	25.75
Sundry Debtors	90.04	61.60	90.34	50.97	44.65	32.88
Cash and Bank	38.58	174.74	3.59	9.82	15.67	7.17
Loans and Advances	31.39	56.09	16.18	8.89	22.20	10.46
Total Current Assets	311.46	453.12	178.47	128.40	113.57	76.25
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	78.34	86.36	53.24	35.22	26.91	27.23
Provisions	0.33	0.37	0.20	0.06	0.04	0.03
Total Current Liabilities	78.67	86.73	53.44	35.29	26.94	27.25
Net Current Assets	232.79	366.39	125.03	93.11	86.63	49.00
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	25.02	19.65	7.22	1.35	0.15	0.69
Deferred Tax Liability	12.66	10.94	9.30	5.80	3.45	2.30
Net Deferred Tax	12.36	8.71	-2.08	-4.45	-3.30	-1.61
Total Assets	672.79	586.87	253.88	205.40	156.74	115.57
Contingent Liabilities	1.46	3.34	0.51	0.68	0.43	0.00

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	22.17	22.17	20.09	8.04	8.04	8.04
Reserves Total	492.63	450.92	145.88	109.66	71.67	51.08
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	514.80	473.09	165.97	117.70	79.71	59.12
Minority Interest	0.00	0.00	0.00	0.00	0.00	0.00
Secured Loans	170.26	119.94	90.25	90.69	77.15	56.15
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	170.26	119.94	90.25	90.69	77.15	56.15
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	1.15	0.66	1.98	0.43	0.33	0.16
Total Liabilities	686.21	593.69	258.20	208.82	157.19	115.43
APPLICATION OF FUNDS :
Gross Block	231.78	186.14	138.88	122.48	73.46	59.99
Less: Accumulated Depreciation	35.53	26.53	18.44	11.30	6.74	2.95
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	196.25	159.61	120.44	111.18	66.72	57.04
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	230.74	51.49	9.81	4.89	6.04	9.94
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.53
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	162.50	169.96	72.02	63.56	35.59	28.82
Sundry Debtors	84.40	56.60	90.74	49.57	41.26	28.81
Cash and Bank	44.76	176.99	5.34	10.83	15.75	7.76
Loans and Advances	21.89	32.10	16.15	8.74	21.79	10.59
Total Current Assets	313.55	435.64	184.25	132.70	114.38	75.97
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	69.56	63.17	54.03	35.61	26.99	26.65
Provisions	0.55	1.20	0.50	0.06	0.04	0.03
Total Current Liabilities	70.11	64.37	54.53	35.67	27.03	26.68
Net Current Assets	243.44	371.27	129.72	97.02	87.35	49.29
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	25.02	19.65	7.22	1.35	0.15	0.69
Deferred Tax Liability	12.66	10.94	9.30	5.80	3.45	2.30
Net Deferred Tax	12.36	8.71	-2.08	-4.45	-3.30	-1.61
Other Assets	3.40	2.60	0.30	0.17	0.38	0.23
Total Assets
Contingent Liabilities	1.46	3.34	0.51	0.70	0.00	0.41

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	60.78	2.73	9.15	15.67	7.17
Net Cash from Operating Activities	23.73	19.76	18.91	24.64	7.87
Net Cash Used In Investing Activities	-101.13	-196.72	-20.61	-40.18	-16.77
Net Cash Used In Financing Activities	37.81	235.01	-4.72	9.70	17.40
Net Inc./Dec In Cash And Cash Equivalents	-39.59	58.05	-6.42	-5.85	8.50
Cash And Cash Equivalents At End Of The Year	21.19	60.78	2.73	9.82	15.67

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

72.02%

FII Shareholding

3.65%

DII Shareholding

12.84%

Public Shareholding

11.49%

**Promoter pledged shareholding 72.02%

About Tatva Chintan Pharma Chem Ltd

Tatva Chintan Pharma Chem Ltd is in the Chemicals sector, having a market capitalization of Rs. 2913.6 crores. It has reported a sales of Rs. 93.93 crores and a net profit of Rs. 8.25 crores for the quarter ended December 2018. The company management includes Chintan Nitinkumar Shah, Chintan Nitinkumar Shah,Ajaykumar Mansukhlal Patel,Shekhar Rasiklal Somani,Subhash Patel,Avani Rajesh Umatt,Manher Chinmanlal Desai (Tatva Chintan Pharma Chem Ltd) among others.

Chairman

Chintan Nitinkumar Shah

Registered office

No 502/17 GIDC Estate,Ankleshwar,Bharuch,Gujarat,393002

FAX :

Background

Incorporation Year1996

Face Value₹10

Market Lot1

How to buy Tatva Chintan shares on nse?

To buy Tatva Chintan shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Tatva Chintan share price today?

The Tatva Chintan shares price on nse is Rs.1245.55 today.

What is the market cap of Tatva Chintan shares on BSE ?

The company has a market capitalization of Rs.2913.60Cr

What is the PE & PB ratio of Tatva Chintan shares ?

PE is 71.34 and PB is 4.07

What is the 52 Week High and Low of Tatva Chintan shares?

Tatva Chintan stock price high: Rs.1888.05 Tatva Chintan stock price low: Rs.1063.35